This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (49)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Tawfiq Khansur, MD; Jane Sanders, MD; Suman K. Das, MD

Arch Surg. 1989;124(7):847-849.

Abstract
• To evaluate the role of staging workup in primary and recurrent malignant melanoma, we reviewed the results in 115 patients with primary melanoma and in 28 patients with recurrent disease who underwent evaluation with chest roentgenograms, radionuclide bone and liver scans, and either a radionuclide brain scan or computed tomography of the brain. Upper gastrointestinal tract series with small-bowel follow-through were obtained in 42 patients. Metastatic disease was documented in nine of 143 chest roentgenograms, seven of 137 liver-spleen scans, three of 141 bone scans, two of 85 brain scans, two of 43 brain computed tomographic scans, and two of 42 upper gastrointestinal tract series. All documented metastasis was in stage II and recurrent melanoma. Postoperatively determined serum lactate dehydrogenase levels showed greater than 300 U/L in all patients with documented metastasis except in two with bone and one with brain metastases. We conclude that, in view of low yield, there is no role for routine metastatic workup to detect silent metastasis in malignant melanoma. Elevated postoperative serum lactate dehydrogenase levels indicate need for metastatic workup.

(Arch Surg 1989;124:847-849)

Author Affiliations
From the Divisions of Medical Oncology (Dr Khansur), Nuclear Medicine (Dr Sanders), and Plastic Surgery (Dr Das), University of Mississippi and Veterans Administration Medical Center, Jackson.

Footnotes
Accepted for publication Sept 1, 1988.

Reprint requests to Veterans Administration Medical Center (151), 1500 E Woodrow Wilson Dr, Jackson, MS 39216 (Dr Khansur).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Staging Workup, Sentinel Node Biopsy, and Follow-up Tests for Melanoma: Update of Current Concepts
Johnson et al.
Arch Dermatol 2004;140:107-113.
ABSTRACT | FULL TEXT  

Prospective Evaluation of a Follow-Up Schedule in Cutaneous Melanoma Patients: Recommendations for an Effective Follow-Up Strategy
Garbe et al.
JCO 2003;21:520-529.
ABSTRACT | FULL TEXT  

Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Micrometastases of Primary Cutaneous Malignant Melanoma
Acland et al.
JCO 2001;19:2674-2678.
ABSTRACT | FULL TEXT  

Prospective Study of Fluorodeoxyglucose–Positron Emission Tomography Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node Biopsy
Wagner et al.
JCO 1999;17:1508-1508.
ABSTRACT | FULL TEXT  

Use of Chest Radiography in the Initial Evaluation of Patients With Localized Melanoma
Terhune et al.
Arch Dermatol 1998;134:569-572.
ABSTRACT | FULL TEXT